PapersFlow Research Brief
Drug-Induced Hepatotoxicity and Protection
Research Guide
What is Drug-Induced Hepatotoxicity and Protection?
Drug-Induced Hepatotoxicity and Protection refers to the study of liver damage caused by drugs through mechanisms such as oxidative stress and mitochondrial dysfunction, along with strategies for prevention and management including antioxidants and biomarkers.
This field encompasses 70,583 papers on mechanisms, risk factors, biomarkers, and management of drug-induced liver injury, with a focus on acetaminophen overdose and idiosyncratic reactions. Acetaminophen overdose and idiosyncratic drug reactions are the leading causes of acute liver failure, surpassing viral hepatitis, as shown in a prospective study across 17 US tertiary care centers. Key protective mechanisms involve glutathione depletion prevention, as demonstrated in bromobenzene-induced liver necrosis models.
Topic Hierarchy
Research Sub-Topics
Acetaminophen-Induced Hepatotoxicity
Investigates mechanisms of NAPQI-mediated oxidative stress, GSH depletion, and mitochondrial dysfunction in acetaminophen overdose liver injury. Studies explore therapeutic interventions like N-acetylcysteine.
Drug Metabolism and Hepatotoxicity
Focuses on cytochrome P450 bioactivation, reactive metabolite formation, and Phase II conjugation pathways contributing to idiosyncratic liver injury. Genetic polymorphisms in metabolizing enzymes are key research targets.
Oxidative Stress in Drug-Induced Liver Injury
Examines ROS generation, lipid peroxidation, antioxidant defense failure, and Nrf2 pathway activation in DILI pathogenesis. Antioxidant therapies and biomarkers of oxidative damage are actively studied.
Biomarkers of Drug-Induced Liver Injury
Develops and validates novel biomarkers like microRNA-122, keratin-18 fragments, and glutamate dehydrogenase for early DILI detection and severity prediction. Comparative studies assess biomarker performance against ALT.
Genetic Risk Factors in Idiosyncratic DILI
Studies HLA associations, pharmacogenetic variants, and genome-wide associations underlying hypersensitivity-mediated idiosyncratic DILI. Immune checkpoint roles and patient stratification are investigated.
Why It Matters
Drug-induced hepatotoxicity accounts for a significant portion of acute liver failure cases, with acetaminophen overdose identified as the primary cause in a multicenter US study involving 17 tertiary care centers (Ostapowicz et al., 2002). Idiosyncratic reactions, often linked to HLA genotypes and CYP3A polymorphisms, complicate drug safety in clinical practice (Kuehl et al., 2001). Protective roles of glutathione against hepatotoxic metabolites, as in bromobenzene studies, inform antidote development like N-acetylcysteine for acetaminophen cases (Jollow et al., 1974). Herbal medicines pose additional risks, with over 80% of the global population relying on them for primary healthcare, necessitating better adverse reaction monitoring (Ekor, 2014). These insights guide liver transplantation decisions in fulminant failure, improving survival rates (O'Grady et al., 1989).
Reading Guide
Where to Start
"DETERMINATION OF SERUM PROTEINS BY MEANS OF THE BIURET REACTION" by Gornall et al. (1949), as it provides a foundational, simple method for serum protein analysis essential for early liver injury studies.
Key Papers Explained
Gornall et al. (1949) "DETERMINATION OF SERUM PROTEINS BY MEANS OF THE BIURET REACTION" establishes basic biochemical assays for liver injury. Jollow et al. (1974) "Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione..." builds on this by linking glutathione to metabolite protection. Ostapowicz et al. (2002) "Results of a Prospective Study of Acute Liver Failure..." applies these concepts clinically, quantifying acetaminophen and idiosyncratic causes. O'Grady et al. (1989) "Early indicators of prognosis in fulminant hepatic failure" extends to prognostic markers. Kuehl et al. (2001) "Sequence diversity in CYP3A promoters..." adds genetic layers influencing toxicity.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus shifts to genetic predictors like CYP3A5 polymorphisms and HLA associations for idiosyncratic reactions, as in Kuehl et al. (2001). Clinical management emphasizes transplantation criteria from O'Grady et al. (1989) and Ostapowicz et al. (2002). Herbal safety monitoring remains critical per Ekor (2014), amid stable paper growth.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | DETERMINATION OF SERUM PROTEINS BY MEANS OF THE BIURET REACTION | 1949 | Journal of Biological ... | 16.1K | ✓ |
| 2 | Apoptosis by Death Factor | 1997 | Cell | 5.0K | ✓ |
| 3 | The growing use of herbal medicines: issues relating to advers... | 2014 | Frontiers in Pharmacology | 3.6K | ✓ |
| 4 | Artemisinin Resistance in <i>Plasmodium falciparum</i> Malaria | 2009 | New England Journal of... | 3.4K | ✓ |
| 5 | Bromobenzene-Induced Liver Necrosis. Protective Role of Glutat... | 1974 | Pharmacology | 3.2K | ✕ |
| 6 | Adverse drug reactions: definitions, diagnosis, and management | 2000 | The Lancet | 2.9K | ✕ |
| 7 | Results of a Prospective Study of Acute Liver Failure at 17 Te... | 2002 | Annals of Internal Med... | 2.2K | ✕ |
| 8 | Clinical Guide to Laboratory Tests. | 1991 | Annals of Internal Med... | 2.2K | ✕ |
| 9 | Sequence diversity in CYP3A promoters and characterization of ... | 2001 | Nature Genetics | 2.1K | ✕ |
| 10 | Early indicators of prognosis in fulminant hepatic failure | 1989 | Gastroenterology | 2.1K | ✕ |
Frequently Asked Questions
What are the main causes of acute liver failure?
Acetaminophen overdose and idiosyncratic drug reactions are the most frequent causes of acute liver failure, replacing viral hepatitis. This was determined in a prospective study at 17 US tertiary care centers. Coma grade at admission influences outcome, with transplantation improving survival when available.
How does glutathione protect against drug-induced liver necrosis?
Glutathione protects against bromobenzene-induced liver necrosis by conjugating the hepatotoxic metabolite 3,4-bromobenzene oxide. Depletion of glutathione correlates with increased necrosis severity. Evidence comes from studies comparing metabolite formation and liver damage.
What role do genetic factors play in drug-induced hepatotoxicity?
Polymorphic CYP3A5 expression due to promoter sequence diversity contributes to variable drug metabolism and hepatotoxicity risk. HLA genotypes are associated with idiosyncratic reactions. These genetic bases affect individual susceptibility to liver injury.
What are early indicators of prognosis in fulminant hepatic failure?
Early indicators of prognosis in fulminant hepatic failure include specific clinical and laboratory markers assessed at admission. These predict survival without transplantation. Studies define thresholds for poor outcomes guiding management.
How prevalent are adverse reactions from herbal medicines?
Not less than 80% of people worldwide rely on herbal medicines for primary healthcare, increasing adverse reaction risks. Challenges include monitoring safety due to growing use over three decades. Herbal products show efficacy but require better safety assessment.
What methods detect serum proteins in liver injury studies?
The biuret reaction provides a simple, rapid, and accurate method for determining serum protein fractions in small serum volumes. It was developed for investigating biochemical changes after experimental liver injury. This technique supports hepatotoxicity research.
Open Research Questions
- ? How can biomarkers reliably predict idiosyncratic drug-induced liver injury before clinical onset?
- ? What are the precise roles of mitochondrial dysfunction and oxidative stress in acetaminophen hepatotoxicity progression?
- ? Which HLA genotypes most strongly associate with specific drug-induced idiosyncratic reactions?
- ? How do CYP3A promoter polymorphisms quantitatively affect hepatotoxic metabolite formation across populations?
- ? What optimal timing and criteria improve liver transplantation outcomes in acetaminophen-induced fulminant failure?
Recent Trends
The field maintains 70,583 papers with no specified 5-year growth rate.
Emphasis persists on acetaminophen overdose as the top acute liver failure cause from Ostapowicz et al.
2002Genetic insights from Kuehl et al. on CYP3A5 continue influencing pharmacogenetics.
2001No recent preprints or news reported in the last 6-12 months.
Research Drug-Induced Hepatotoxicity and Protection with AI
PapersFlow provides specialized AI tools for Pharmacology, Toxicology and Pharmaceutics researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Drug-Induced Hepatotoxicity and Protection with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Pharmacology, Toxicology and Pharmaceutics researchers